Global Refurbished Medical Equipment Market to be Worth $8.45 Billion by 2017
According to a new report, "Refurbished Medical Equipments Market - By Device Types & Applications (2012-2017) - Global Trends & Competitive Analysis," published by MarketsandMarkets.com, the global refurbished market has seen challenging and dynamic market conditions but still remains strong, with a size of approximately $8.45 billion in 2017 and an estimated annual growth rate of 7.8 percent over the next five years. Affordable offerings of used branded products and enhanced access to replacement parts and repair technology are contributing to widespread adoption of the refurbished medical devices by healthcare institutions worldwide.
Refurbishing of medical device refers to restoring used equipment or systems into a condition of safety and effectiveness comparable to new including actions such as repair, rework, update and replacement of worn parts with original parts. Refurbished products do not alter any product specification like remanufactured products, thus requiring no special approval to market the refurbished products in different countries. Refurbished medical devices represent the aftermarket of used medical devices worldwide. As per standard definition, refurbished devices hold a niche market which is different from remanufactured and used devices market.
The global refurbished devices market is classified into imaging-diagnostic-monitoring devices, minimally invasive surgical devices, radiation oncology devices, biotechnology instruments and so others. Refurbished medical devices market is expected to grow at a faster rate with a CAGR of 7.8 percent from 2012 to 2017.
The refurbished medical equipments market is operated by mainly two kinds of players -- original equipment manufacturers (OEMs) and third-party manufacturers. Major OEMs include GE Healthcare (UK), Siemens Healthcare (Germany), Philips Healthcare (The Netherlands), Stryker Corporation (U.S.), Johnson & Johnson (U.S.) and Toshiba Medical System (Japan), and third-party vendors including Soma Technology (U.S.), Agito Medical (Denmark), DMS Topline Medical (U.S.), and First Source, Inc. (U.S.).
Source: MarketsandMarkets
Unmasking Vaccine Myths: Dr Marschall Runge on Measles, Misinformation, and Public Health Solutions
May 29th 2025As measles cases climb across the US, discredited myths continue to undercut public trust in vaccines. In an exclusive interview with Infection Control Today, Michigan Medicine’s Marschall Runge, PhD, confronts misinformation head-on and explores how clinicians can counter it with science, empathy, and community engagement.
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.
Endoscopes and Lumened Instruments: New Studies Highlight Persistent Contamination Risks
May 7th 2025Two new studies reveal troubling contamination in both new endoscopes and cleaned lumened surgical instruments, challenging the reliability of current reprocessing practices and manufacturer guidelines.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
